APA

Ignatowska-Jankowska B. M., Ghosh S., Crowe M. S., Kinsey S. G., Niphakis M. J., Abdullah R. A., Tao Q., O' Neal S. T., Walentiny D. M., Wiley J. L., Cravatt B. F. & Lichtman A. H. (20141105). In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. : British journal of pharmacology.

Chicago

Ignatowska-Jankowska B M, Ghosh S, Crowe M S, Kinsey S G, Niphakis M J, Abdullah R A, Tao Q, O' Neal S T, Walentiny D M, Wiley J L, Cravatt B F and Lichtman A H. 20141105. In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. : British journal of pharmacology.

Harvard

Ignatowska-Jankowska B. M., Ghosh S., Crowe M. S., Kinsey S. G., Niphakis M. J., Abdullah R. A., Tao Q., O' Neal S. T., Walentiny D. M., Wiley J. L., Cravatt B. F. and Lichtman A. H. (20141105). In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. : British journal of pharmacology.

MLA

Ignatowska-Jankowska B M, Ghosh S, Crowe M S, Kinsey S G, Niphakis M J, Abdullah R A, Tao Q, O' Neal S T, Walentiny D M, Wiley J L, Cravatt B F and Lichtman A H. In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. : British journal of pharmacology. 20141105.